Your browser doesn't support javascript.
loading
Amyloid beta25-35 impairs docosahexaenoic acid efflux by down-regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells.
Ochiai, Yusuke; Uchida, Yasuo; Tachikawa, Masanori; Couraud, Pierre-Olivier; Terasaki, Tetsuya.
Afiliação
  • Ochiai Y; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Uchida Y; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Tachikawa M; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Couraud PO; Institut Cochin, Inserm U1016, CNRS UMR8104, Paris Descartes University, Sorbonne Paris City, Paris, France.
  • Terasaki T; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
J Neurochem ; 150(4): 385-401, 2019 08.
Article em En | MEDLINE | ID: mdl-31091338
ABSTRACT
Decreased levels of docosahexaenoic acid (DHA), an endogenous neuroprotective compound, in the brain are associated with the development of Alzheimer's disease (AD). We previously showed that DHA is a substrate of fatty acid transport protein 1 (FATP1/SLC27A1), and FATP1 is localized at the abluminal membrane of brain capillary endothelial cells. We hypothesized that amyloid ß (Aß) decreases FATP1-mediated cellular efflux (i.e. supply to the brain) of DHA at the blood-brain barrier (BBB). Here, we tested this hypothesis using a human cerebral microvascular endothelial cell line, human cerebral microvessel endothelial cells (hCMEC/D3), as a BBB model. The efflux of DHA-d5 by hCMEC/D3 cells increased time-dependently up to 3 min. Knock-down of FATP1 with specific siRNA indicated that FATP1-mediated efflux accounts for 47.0% of this DHA-d5 efflux. In hCMEC/D3 cells treated with Aß25-35 (10 µM/24 h), which we employed as an in vitro model of the BBB in AD, FATP1 protein expression in the plasma membrane was decreased by 96.0%, which was greater than the decrease in the whole-cell lysate, and the DHA-d5 efflux was decreased by 68.3%. Of this 68.3% decrease, 45.1% (47.0 × 0.96) is accounted for by the decrease in FATP1-mediated efflux and the remaining 23.2% is presumably mediated by other mechanism(s). Thus, we have established for the first time that FATP1 is a major contributor to DHA efflux from human brain capillary endothelial cells, and its efflux activity at the abluminal membrane of the cells is blocked by Aß. This may explain the decreased DHA level in the brain of AD patients. OPEN SCIENCE BADGES This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https//cos.io/our-services/open-science-badges/.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Barreira Hematoencefálica / Ácidos Docosa-Hexaenoicos / Peptídeos beta-Amiloides / Proteínas de Transporte de Ácido Graxo Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Barreira Hematoencefálica / Ácidos Docosa-Hexaenoicos / Peptídeos beta-Amiloides / Proteínas de Transporte de Ácido Graxo Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article